JC virus in the Irish population: Significant increase of genotype 2 in immunocompromised individuals

References

• Agostini H T, Deckhut A, Jobes D V, Girones R, Schlunck G, Prost M G, Frias C, Perez-Trallero E, Ryschkewitsch C F, Stoner G L. Genotypes of JC virus in East, Central and Southwest Europe. J Gen Virol 2001; 82: 1221–1331, [PUBMED], [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Agostini H T, Ryschkewitsch C F, Mory R, Singer E J, Stoner G L. JC virus (JCV) genotypes in brain tissue from patients with progressive multifocal leukoencephalopathy (PML) and in urine from controls without PML: increased frequency of JCV type 2 in PML. J Infect Dis 1997; 176: 1–8, [PUBMED], [INFOTRIEVE], [CSA]
   Google Scholar
• Agostini H T, Ryschkewitsch C F, Singer E J, Baumhefner R W, Stoner G L. JC virus type 2B is found more frequently in brain tissue of progressive multifocal leukoencephalopathy patients than in urine from controls. J Hum Virol 1998a; 3: 200–206, [CSA]
   Google Scholar
• Agostini H T, Ryschkewitsch C F, Stoner G J. JC virus type 1 has multiple subtypes: three new complete genomes. J Gen Virol 1998b; 79: 801–805, [PUBMED], [INFOTRIEVE], [CSA]
   Google Scholar
• Agostini H T, Shishido-Hara Y, Baumhefner R W, Singer E J, Ryschkewitsch C F, Stoner G L. JC virus type 2: definition of subtypes based on DNA sequence analysis of ten complete genomes. J Gen Virol 1998c; 79: 1143–1151, [PUBMED], [INFOTRIEVE], [CSA]
   Google Scholar
• Behzad-Behbahani A, Klapper P E, Vallely P J, Cleator G M, Khoo S H. Detection of BK virus and JC virus DNA in urine samples from immunocompromised (HIV-infected) and immunocompetent (HIV-non-infected) patients using polymerase chain reaction and microplate hybridisation. J Clin Virol 2004; 29: 224–229, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Berger J R. Progressive multifocal leukoencephalopathy in acquired immunodeficiency syndrome: Explaining the high incidence and disproportionate frequency of the illness relative to other immunosuppressive conditions. J NeuroVirol 2003; 9(Suppl l)38–41, [PUBMED], [INFOTRIEVE], [CSA]
   Google Scholar
• Centers for Disease Control and Prevention (CDC). Tuberculosis associated with blocking agents against tumor necrosis factor-alpha-California, 2002–2003. MMWR Morb Mortal Wkly Rep 2004; 53: 683–686, [CSA]
   PubMedGoogle Scholar
• Daniel D C, Wortman M J, Schiller R J, Liu H, Gan L, Mellen J S, Chang C -F, Gallia G L, Rappaport J, Khalili K, Johnson E M. Coordinate effects of human immunodeficiency virus type 1 protein Tat and cellular protein Purα on DNA replication initiated at the JC virus origin. J Gen Virol 2001; 82: 1543–1553, [PUBMED], [INFOTRIEVE], [CSA]
   PubMedGoogle Scholar
• Dubois V, Moret H, Lafon M -E, Brodard V, Icart J, Ruffault A, Guist'hau O, Buffet-Janvresse C, Abbed K, Dussaix E, Ingrand D. JC virus genotypes in France: molecular epidemiology and potential significance for progressive multifocal leukoencephalopathy. J Infect Dis 2001; 183: 213–217, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
   Google Scholar
• Ferrante P, Mediati M, Caldarelli-Stefano R, Losciale L, Manusco R, Cagni A E, Maserati R. Increased frequency of JC virus type 2 and of dual infection with JC virus type 1 and 2 in Italian progressive multifocal leukoencephalopathy patients. J NeuroVirol 2001; 7: 35–42, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Frisque R J, Bream G L, Cannella M T. Human polyomavirus JC virus genome. J Virol 1984; 51: 458–469, [PUBMED], [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Hatwell J N, Sharp P M. Evolution of human polyomavirus JC. J Gen Virol 2000; 81: 1191–1200, [PUBMED], [INFOTRIEVE], [CSA]
   Google Scholar
• Kitamura T, Kunitake T, Quo J, Tominaga T, Kawabe K, Yogo Y. Transmission of the human polyomavirus JC virus occurs both within the family and outside the family. J Clin Microbiol 1994; 32: 2359–2363, [PUBMED], [INFOTRIEVE], [CSA]
   PubMedGoogle Scholar
• Kleinschmidt-DeMasters B K, Tyler K L. Progressive multifocal leukoencephalopathy complicating treatment with natalizumab and interferon beta-1a for multiple sclerosis. N Engl J Med 2005; 353: 369–374, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Krachmarov C P, Chepenik L G, Barr-Vagell S, Khalili K, Johnson E M. Activation of the JC virus Tat-responsive transcriptional control element by association of the Tat protein of human immunodeficiency virus 1 with cellular protein Purα. Proc Natl Acad Sci U S A 1996; 93: 14112–14117, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
   PubMedGoogle Scholar
• Lednicky J A, Vilchez R A, Keitel W A, Visnegarwala F, White Z S, Kozinetz C A, Lewis D E, Butel J S. Polyomavirus JCV excretion and genotype analysis in HIV-infected patients receiving highly active antiretroviral therapy. AIDS 2003; 17: 801–807, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
   Google Scholar
• Major E O. Human polyomavirus. Virology, B N Fields, P M Howley, D E Griffin, R A Lamb, M A Martin, B Roizman, S E Strauss, D M Knipe. Lippincott Williams, Philadelphia 2001; 2175–2196
   Google Scholar
• Pagani E, Delbue S, Manusco R, Borghi E, Tarantini L, Ferrante P. Molecular analysis of JC virus genotypes circulating among the Italian healthy population. J NeuroVirol 2003; 9: 559–566, [PUBMED], [INFOTRIEVE], [CSA]
   PubMedGoogle Scholar
• Stolt A, Sasnauskas K, Koskela P, Lehtinen M, Dillner J. Seroepidemiology of the human polyomaviruses. J Gen Virol 2003; 84: 1499–1504, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Sundsfjord A, Flaegstad T, Flo R, Spein A R, Pedersen M, Permin H, Julsrud J, Traavik T. BK and JC viruses in human immunodeficiency virus type 1-infected persons: prevalence, excretion, viremia, and viral regulatory regions. J Infect Dis 1994; 169: 485–490, [PUBMED], [INFOTRIEVE], [CSA]
   Google Scholar
• Tsai R -T, Wang M, Ou W -C, Lee Y -L, Li S -Y, Fung C -Y, Huang Y -L, Tzeng T -Y, Chen Y, Chang D. Incidence of JC viruria is higher than that of BK viruria in Taiwan. J Med Virol 1997; 52: 253–257, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
   Google Scholar
• Van Assche G, Van Raust M, Sciot R, Dubois B, Vermeire S, Noman M, Verbeeck J, Geboes K, Robberecht W, Rutgeerts P. Progressive multifocal leukoencephalopathy after natalizumab therapy for Chron's disease. N Engl J Med 2005; 353(4)362–368, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Venter M, Smit S B, Leman P, Swanepoel R. Phylogenetic evidence of widespread distribution of genotype 3 JC virus in Africa and identification of a type 7 isolate in an African AIDS patient. J Gen Virol 2004; 85: 2215–2219, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
   Google Scholar
• Wang M, Tsai R -T, Ou W -C, Lin C -K, Tsay G J, Chang H, Chang D. Treatment with cytotoxic immunosuppression agents increases urinary excretion of JCV in patients with autoimmune disease. J Med Virol 2000; 62: 505–510, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
   Google Scholar
• Yanagihara R, Nerurkar V R, Scheirich I, Agostini H T, Mgone C S, Cui X, Jobes D V, Cubitt C L, Ryschkewitsch C F, Hroly D B, Friedlaender J S, Stoner G L. JC virus genotypes in the western Pacific suggest Asian mainland relationships and virus association with early population movements. Hum Biol 2002; 74: 473–488, [PUBMED], [INFOTRIEVE], [CSA]
   PubMedGoogle Scholar
• Zheng H -Y, Takasaka T, Noda K, Kanazawa A, Mori H, Kabuki T, Joh K, Oh-ishi T, Ikegaya H, Nagashima K, Hall W W, Kitamura T, Yogo Y. New sequence polymorphisms in the outer loops of the JC polyomavirus major capsid protein (VP1) possibly associated with progressive multifocal leukoencephalopathy. J Gen Virol 2005; 86: 2035–2045, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
   Google Scholar